Page results
-
A front page story and patient case study highlight SUMMIT Study early diagnosis outcomes.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Tuesday 31 January 2023.
-
This page explains what a gastroscopy is and what it involves for patients on a standard diet.
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
A UCLH/UCL clinical trial of a personalised therapy for blood cancer has been expanded, meaning new groups of patients with a wider range of blood cancers are now receiving the treatment.
-
A large trial at UCLH and UCL will investigate whether a drug currently in use to treat respiratory conditions can slow the progress of Parkinson’s disease.
-
A patient with motor neurone disease was able to control a computer just by using his thoughts following the UK’s first Neuralink implant surgery at UCLH’s National Hospital for Neurology and Neurosurgery (NHNN) in October 2025.
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 28 January 2026.
File results
-
FOI/2024/0481 - Maternity unit closed to new admissions 2018-2023
-
FOI/2023/0481 - Closure of maternity unit to new admissions 2018/23
-
FOI/2023/0485 - Heart attacks 2019/22
-
FOI/2023/0487 - Maintenance of corporate estate
-
FOI/2023/0488 - Electronic Patient Record (EPR)
-
FOI/2023/0491 - Treatment for oesophageal and gastric cancer
-
FOI/2023/0493 - Treatments for various diseases
-
FOI/2023/0497 - List of all laboratories within Pathology
-
FOI/2023/0499 - Treatments for non-small cell lung cancer
-
FOI/2023/0500 - Treatment of urothelial and colorectal cancer